DE3874465T2 - 1,2,3,4-tetrahydroisochonoline als antiarrhythmische mittel. - Google Patents

1,2,3,4-tetrahydroisochonoline als antiarrhythmische mittel.

Info

Publication number
DE3874465T2
DE3874465T2 DE8888307351T DE3874465T DE3874465T2 DE 3874465 T2 DE3874465 T2 DE 3874465T2 DE 8888307351 T DE8888307351 T DE 8888307351T DE 3874465 T DE3874465 T DE 3874465T DE 3874465 T2 DE3874465 T2 DE 3874465T2
Authority
DE
Germany
Prior art keywords
methoxy
formula
hydroxy
pharmaceutically acceptable
compound
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8888307351T
Other languages
German (de)
English (en)
Other versions
DE3874465D1 (de
Inventor
Nigel John Dr Cussans
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Ltd Great Britain
Original Assignee
Pfizer Ltd Great Britain
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Ltd Great Britain filed Critical Pfizer Ltd Great Britain
Application granted granted Critical
Publication of DE3874465D1 publication Critical patent/DE3874465D1/de
Publication of DE3874465T2 publication Critical patent/DE3874465T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
    • C07D217/02—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines
    • C07D217/06—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with only hydrogen atoms or radicals containing only carbon and hydrogen atoms, directly attached to carbon atoms of the nitrogen-containing ring; Alkylene-bis-isoquinolines with the ring nitrogen atom acylated by carboxylic or carbonic acids, or with sulfur or nitrogen analogues thereof, e.g. carbamates

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
DE8888307351T 1987-08-15 1988-08-09 1,2,3,4-tetrahydroisochonoline als antiarrhythmische mittel. Expired - Fee Related DE3874465T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB878719378A GB8719378D0 (en) 1987-08-15 1987-08-15 Antiarrythmic agents

Publications (2)

Publication Number Publication Date
DE3874465D1 DE3874465D1 (de) 1992-10-15
DE3874465T2 true DE3874465T2 (de) 1993-02-25

Family

ID=10622374

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8888307351T Expired - Fee Related DE3874465T2 (de) 1987-08-15 1988-08-09 1,2,3,4-tetrahydroisochonoline als antiarrhythmische mittel.

Country Status (13)

Country Link
US (1) US4965360A (https=)
EP (1) EP0308059B1 (https=)
JP (1) JP2800830B2 (https=)
AT (1) ATE80395T1 (https=)
CA (1) CA1332415C (https=)
DE (1) DE3874465T2 (https=)
DK (1) DK171299B1 (https=)
ES (1) ES2051856T3 (https=)
FI (1) FI90420C (https=)
GB (1) GB8719378D0 (https=)
GR (1) GR3005840T3 (https=)
IE (1) IE61749B1 (https=)
PT (1) PT88256B (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9711650D0 (en) * 1997-06-05 1997-07-30 Pfizer Ltd Compounds useful in therapy
GB0112061D0 (en) * 2001-05-18 2001-07-11 Pfizer Ltd Process for the production of quinazolines
GB0118752D0 (en) * 2001-08-01 2001-09-26 Pfizer Ltd Process for the production of quinazolines
KR100863692B1 (ko) * 2006-12-08 2008-10-15 울산대학교 산학협력단 퇴행성질환 및 염증질환에 대한 예방치료 효과를 갖는7-하이드록시-6-메톡시-1,2,3,4-테트라하이드로이소퀴놀린유도체
KR100870576B1 (ko) * 2008-08-27 2008-11-27 울산대학교 산학협력단 퇴행성질환 및 염증질환에 대한 예방치료 효과를 갖는 7-하이드록시-6-메톡시-1,2,3,4-테트라하이드로이소퀴놀린 유도체

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3855228A (en) * 1972-08-21 1974-12-17 Sterling Drug Inc 3,4-dihydro-1-or 3-(polyfluoroalkyl)-2(1h)-isoquinolinecarboxamidoximes
US4656174A (en) * 1982-07-24 1987-04-07 Pfizer Inc. Quinoline therapeutic agents

Also Published As

Publication number Publication date
GB8719378D0 (en) 1987-09-23
FI90420B (fi) 1993-10-29
IE882474L (en) 1989-02-15
JP2800830B2 (ja) 1998-09-21
ES2051856T3 (es) 1994-07-01
PT88256A (pt) 1989-06-30
JPH01110680A (ja) 1989-04-27
DK452088A (da) 1989-02-16
DE3874465D1 (de) 1992-10-15
IE61749B1 (en) 1994-11-30
US4965360A (en) 1990-10-23
DK452088D0 (da) 1988-08-12
FI883760A0 (fi) 1988-08-12
FI90420C (fi) 1994-02-10
GR3005840T3 (https=) 1993-06-07
EP0308059A1 (en) 1989-03-22
EP0308059B1 (en) 1992-09-09
FI883760L (fi) 1989-02-16
ATE80395T1 (de) 1992-09-15
DK171299B1 (da) 1996-08-26
PT88256B (pt) 1995-03-01
CA1332415C (en) 1994-10-11

Similar Documents

Publication Publication Date Title
DE3152880C2 (https=)
DE2934747C2 (https=)
DE2366106C2 (de) 2-Amino-6,7-dimethoxy-4-(methoxysubstituierte-lÄ3»4-tetrahydroisochinolin-2-yl)-chinazolinderivate, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
AT363096B (de) Verfahren zur herstellung von neuen phthalazinderivaten und deren salzen
EP0528922B1 (de) Neue sulfonylverbindungen
EP0047923B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen
DE2238504B2 (de) l-Phenoxy-3-alkylaminopropan-2-ol -Derivate
DE3622036A1 (de) Benzimidazolderivate
EP0105210B1 (de) Isochinolinderivate, Verfahren zu ihrer Herstellung, pharmazeutische Präparate auf Basis dieser Verbindungen und ihre Verwendung
DE3230209A1 (de) Carbostyrilderivate, verfahren zu deren herstellung und arzneimittel, welche diese enthalten
DE3874465T2 (de) 1,2,3,4-tetrahydroisochonoline als antiarrhythmische mittel.
DE69007837T2 (de) Substituierte 1-[3-Heteroarylmethoxyphenyl]alkanole und verwandte Verbindungen, für die Behandlung von Asthma, Arthritis und ähnlichen Krankheiten.
DE3049959C2 (https=)
DE2410938A1 (de) Chinazolinderivate und diese enthaltende arzneimittel
DD143254A5 (de) Verfahren zur herstellung von tetrahydroisochinolin-derivaten
DE1914571B2 (de) L-3hydroxy-6-oxomorphinan-verbindungen
DD280965A5 (de) Verfahren zur herstellung von antiarrhythmisch wirkenden mitteln
DE2724478C2 (de) 5,11-Dihydro-6H-pyrido[2,3-b][1,4]benzodiazepin-6-on-derivate, Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneimittel
DE68912252T2 (de) Imidazolantiarrythmische Mittel.
DE2854727A1 (de) Polyfluorhydroxyisopropyl-substituierte bicyclische und tricyclische carbostyrile, verfahren zu ihrer herstellung und sie enthaltende arzneimittel
DE69424816T2 (de) N-Benzylpiperazinverbindungen, Verfahren zu ihrer Herstellung und sie enthaltende Zusammensetzungen
EP0180833B1 (de) 4-Oxo-pyrido[2,3]pyrimidin-Derivate, Verfahren zur deren Herstellung und diese ethaltende Arzneimittel
DE2024049C3 (de) a-(3,4-Dihydroxyphenyl)-a- (2-piperidinyl)methanol
DE2914935A1 (de) Antidiabetische verwendung von anthranilsaeurederivaten
DE1901637A1 (de) Indolyltetrahydropyridine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee